OBJECTIVE: In multiple endocrine neoplasia type 1, the main risk factor for metastases is
pancreatic tumour size. We and others recommend limiting surgery to non-functioning …

Background Recent clinical practice guidelines recommend that routine screening of MEN1
mutation carriers should start at the age of 5 years. The occurrence of clinically relevant …

Simple Summary In endocrinology, endoscopic ultrasound is a useful and reliable
diagnostic technique in the assessment of multiple endocrine neoplasia type 1, localizing …

Multiple endocrine neoplasia type 1 (MEN1) is a rare disease caused by mutations in the
MEN1 gene on chromosome 11. It is characterized by the occurrence of primary …

In this article, we aimed to review the literature on the clinics and management of
nonfunctional pancreatic neuroendocrine tumors (NPNET). Pancreatic neuroendocrine …

A suspected pancreatic lesion can be a difficult challenge for the clinician. In the last years
we have witnessed tumultuous technological improvements of the radiological and nuclear …

Compared to other imaging methods, endoscopic ultrasound is the best procedure to
localize insulinomas preoperatively. Positive finding furthermore confirms endocrinological …

Multiple endocrine neoplasia type 1 is a rare autosomal inherited disorder associated with a
high risk for patients to simultaneously develop tumors of the parathyroid glands …

Pancreatic neuroendocrine tumours (PanNETs) are considered a relatively unusual
oncologic entity. Due to its relative good prognosis, surgery remains the goal standard …

Prospective randomized data are lacking, but current clinical expert guidelines recommend
annual screening examinations, including laboratory assessments and various imaging …